Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Unknown 2Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lung Neoplasms 1Fistula 1Digestive System Diseases 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Anus Neoplasms 1

Interventions

Paclitaxel 62Letrozole 55Fulvestrant 55Trastuzumab 50palbociclib 41pembrolizumab 37Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25Tamoxifen 24Capecitabine 24ribociclib 23abemaciclib 23Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17durvalumab 16Epirubicin 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Goserelin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Tomography, X-Ray Computed × Clear all
NCT03697577 2026-05-29

CDK and Body Composition Study

Montefiore Medical Center

Active not recruiting
30 enrolled
Breast

Breast Neoplasms

NCT02297672 2026-02-02

PBSI

British Columbia Cancer Agency

Phase NA Active not recruiting
75 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡